10 results on '"D J, Bekedam"'
Search Results
2. Pessary for prevention of preterm birth in twin pregnancy with short cervix: 3-year follow-up study
- Author
-
J, van 't Hooft, J H, van der Lee, B C, Opmeer, A G, van Wassenaer-Leemhuis, A L, van Baar, D J, Bekedam, L J P, Steenis, S, Liem, E, Schuit, C, Cuijpers, E, Bleeker, M E, Vinke, N, Simons, I M, de Graaf, B W J, Mol, and C, van de Beek
- Subjects
Adult ,Male ,Infant, Newborn ,Pregnancy Outcome ,Gestational Age ,Cervix Uteri ,Pessaries ,Statistics, Nonparametric ,Cervical Length Measurement ,Neurodevelopmental Disorders ,Pregnancy ,Child, Preschool ,Pregnancy, Twin ,Humans ,Premature Birth ,Female ,Follow-Up Studies - Abstract
A recent randomized clinical trial (ProTWIN) showed that a cervical pessary prevented preterm birth and improved neonatal outcome in women with multiple pregnancy and cervical length (CL) 38 mm. In this follow-up study, the long-term developmental outcome of these children was evaluated at 3 years' corrected age.This was a follow-up study of ProTWIN, a multicenter trial conducted between 2009 and 2012 in which asymptomatic women with a multiple pregnancy were randomized to placement of a cervical pessary or no intervention. Current follow-up and analysis were limited to mothers with a mid-trimester CL 38 mm (78 women (157 children) in the pessary group and 55 women (111 children) in the control group). At 3 years of corrected age, surviving children were invited for a Bayley Scales of Infant and Toddler Development-third edition (Bayley-III) assessment. Death after randomization or neurodevelopmental disability (Bayley-III score of ≤ 85, 1 SD below mean) rates were compared between the pessary and control groups, according to the intention-to-treat principle and using multiple imputation for missing data. Mean Bayley-III scores in surviving children were also assessed. A linear mixed-effects model was used to adjust for correlation between children of one mother.From the time of entry in the ProTWIN trial until follow-up at 3 years of age, a total of 27 children had died (six (5%) in the pessary vs 21 (26%) in the control group; odds ratio (OR), 0.13; 95% CI, 0.04-0.48). Bayley-III outcomes were collected for 173/241 (72%) surviving children (114 (75%) in the pessary vs 59 (66%) in the control group). The cumulative incidence of death or survival with a neurodevelopmental disability was 12 (10%) in the pessary vs 23 (29%) in the control group (OR, 0.26; 95% CI, 0.09-0.73). No statistical or clinically relevant differences were found with respect to cognitive, language and motor development among surviving children between the groups. Comparable results were found after multiple imputation.In women with twin pregnancy and a CL 38 mm, the use of a cervical pessary strongly improved survival of the children without affecting neurodevelopment at 3 years' corrected age. Copyright © 2018 ISUOG. Published by John WileySons Ltd.
- Published
- 2017
3. A multivariable model to guide the decision for pessary placement to prevent preterm birth in women with a multiple pregnancy: a secondary analysis of the ProTWIN trial
- Author
-
P, Tajik, M, Monfrance, J, van 't Hooft, S M S, Liem, E, Schuit, K W M, Bloemenkamp, J J, Duvekot, B, Nij Bijvank, M T M, Franssen, M A, Oudijk, H C J, Scheepers, J M, Sikkema, M, Woiski, B W J, Mol, D J, Bekedam, P M, Bossuyt, and M H, Zafarmand
- Subjects
Adult ,Decision Making ,Reproducibility of Results ,Prenatal Care ,Cervix Uteri ,Pessaries ,Cervical Length Measurement ,Pregnancy ,Multivariate Analysis ,Humans ,Premature Birth ,Female ,Pregnancy, Multiple ,Netherlands - Abstract
The ProTWIN Trial (NTR1858) showed that, in women with a multiple pregnancy and a cervical length 25(th) percentile (38 mm), prophylactic use of a cervical pessary reduced the risk of adverse perinatal outcome. We investigated whether other maternal or pregnancy characteristics collected at baseline can improve identification of women most likely to benefit from pessary placement.ProTWIN is a multicenter randomized trial in which 808 women with a multiple pregnancy were assigned to pessary or control. Using these data we developed a multivariable logistic model comprising treatment, cervical length, chorionicity, pregnancy history and number of fetuses, and the interaction of these variables with treatment as predictors of adverse perinatal outcome.Short cervix, monochorionicity and nulliparity were predictive factors for a benefit from pessary insertion. History of previous preterm birth and triplet pregnancy were predictive factors of possible harm from pessary. The model identified 35% of women as benefiting (95% CI, 32-39%), which is 10% more than using cervical length only (25%) for pessary decisions. The model had acceptable calibration. We estimated that using the model to guide the choice of pessary placement would reduce the risk of adverse perinatal outcome significantly from 13.5% when no pessary is inserted to 8.1% (absolute risk reduction, 5.4% (95% CI, 2.1-8.6%)).We developed and internally validated a multivariable treatment selection model, with cervical length, chorionicity, pregnancy history and number of fetuses. If externally validated, it could be used to identify women with a twin pregnancy who would benefit from a pessary, and lead to a reduction in adverse perinatal outcomes in these women. Copyright © 2016 ISUOG. Published by John WileySons Ltd.
- Published
- 2015
4. Second-trimester cervical length as risk indicator for Cesarean delivery in women with twin pregnancy
- Author
-
L, van de Mheen, E, Schuit, S M S, Liem, A C, Lim, D J, Bekedam, S M T A, Goossens, M T M, Franssen, M M, Porath, M A, Oudijk, K W M, Bloemenkamp, J J, Duvekot, M D, Woiski, I, de Graaf, J M, Sikkema, H C J, Scheepers, J, van Eijk, C J M, de Groot, M G, van Pampus, and B W J, Mol
- Subjects
Adult ,Labor, Obstetric ,Cesarean Section ,Infant, Newborn ,Cervix Uteri ,Pregnancy Complications ,Cervical Length Measurement ,Predictive Value of Tests ,Pregnancy ,Reference Values ,Risk Factors ,Pregnancy Trimester, Second ,Pregnancy, Twin ,Humans ,Female ,Netherlands ,Randomized Controlled Trials as Topic - Abstract
To determine whether second-trimester cervical length (CL) in women with a twin pregnancy is associated with the risk of emergency Cesarean section.This was a secondary analysis of two randomized trials conducted in 57 hospitals in The Netherlands. We assessed the univariable association between risk indicators, including second-trimester CL in quartiles, and emergency Cesarean delivery using a logistic regression model. For multivariable analysis, we assessed whether adjustment for other risk indicators altered the associations found in univariable (unadjusted) analysis. Separate analyses were performed for suspected fetal distress and failure to progress in labor as indications for Cesarean section.In total, 311 women with a twin pregnancy attempted vaginal delivery after 34 weeks' gestation. Emergency Cesarean delivery was performed in 111 (36%) women, of which 67 (60%) were performed owing to arrest of labor. There was no relationship between second-trimester CL and Cesarean delivery (adjusted odds ratio (aOR): 0.97 for CL 26(th) -50(th) percentiles; 0.71 for CL 51(st) - 75(th) percentiles; and 0.92 for CL75(th) percentile, using CL ≤ 25(th) percentile as reference). In multivariable analysis, the only variables associated with emergency Cesarean delivery were maternal age (aOR, 1.07 (95% CI, 1.00-1.13)), body mass index (BMI) (aOR, 3.99 (95% CI, 1.07-14.9) for BMI 20-23 kg/m(2) ; 5.04 (95% CI, 1.34-19.03) for BMI 24-28 kg/m(2) ; and 3.1 (95% CI, 0.65-14.78) for BMI28 kg/m(2) ) and induction of labor (aOR, 1.92 (95% CI, 1.05-3.5)).In nulliparous women with a twin pregnancy, second-trimester CL is not associated with risk of emergency Cesarean delivery.
- Published
- 2014
5. Economic analysis of use of pessary to prevent preterm birth in women with multiple pregnancy (ProTWIN trial)
- Author
-
S M S, Liem, G J, van Baaren, F M C, Delemarre, I M, Evers, G, Kleiverda, A J, van Loon, J, Langenveld, N, Schuitemaker, J M, Sikkema, B C, Opmeer, M G, van Pampus, B W J, Mol, and D J, Bekedam
- Subjects
Adult ,Cost-Benefit Analysis ,Pregnancy Outcome ,Prenatal Care ,Cervix Uteri ,Pessaries ,Models, Economic ,Cervical Length Measurement ,Pregnancy ,Humans ,Premature Birth ,Female ,Pregnancy, Multiple ,Randomized Controlled Trials as Topic - Abstract
To assess the cost-effectiveness of a cervical pessary to prevent preterm delivery in women with a multiple pregnancy.The study design comprised an economic analysis of data from a randomized clinical trial evaluating cervical pessaries (ProTWIN). Women with a multiple pregnancy were included and an economic evaluation was performed from a societal perspective. Costs were estimated between the time of randomization and 6 weeks postpartum. The prespecified subgroup of women with a cervical length (CL)25(th) centile (38 mm) was analyzed separately. The primary endpoint was poor perinatal outcome occurring up to 6 weeks postpartum. Direct medical costs and health outcomes were estimated and incremental cost-effectiveness ratios for costs to prevent one poor outcome were calculated.Mean costs in the pessary group (n = 401) were € 21,783 vs € 21,877 in the group in which no pessary was used (n = 407) (difference, -€ 94; 95% CI, -€ 5975 to € 5609). In the prespecified subgroup of women with a CL38 mm we demonstrated a significant reduction in poor perinatal outcome (12% vs 29%; RR, 0.40; 95% CI, 0.19-0.83). Mean costs in the pessary group (n = 78) were € 25,141 vs € 30,577 in the no-pessary group (n = 55) (difference, -€ 5436 (95% CI, -€ 11,001 to € 1456). In women with a CL38 mm, pessary treatment was the dominant strategy (more effective and less costly) with a probability of 94%.Cervical pessaries in women with a multiple pregnancy involve costs comparable to those in women without pessary treatment. However, in women with a CL38 mm, treatment with a cervical pessary appears to be highly cost-effective.
- Published
- 2014
6. Does 17-α-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?
- Author
-
E J H, Mulder, E M J, Versteegh, K W M, Bloemenkamp, A C, Lim, B W J, Mol, D J, Bekedam, A, Kwee, H W, Bruinse, and G C M L, Christiaens
- Subjects
Adult ,Male ,Biometry ,Pregnancy Trimester, Third ,Infant, Newborn ,Twins ,Gestational Age ,Obstetric Labor, Premature ,Sex Factors ,Treatment Outcome ,Pregnancy ,Risk Factors ,Pregnancy Trimester, Second ,17 alpha-Hydroxyprogesterone Caproate ,Hydroxyprogesterones ,Pregnancy, Twin ,Birth Weight ,Body Size ,Humans ,Female ,Progestins - Abstract
Increasingly, maternal administration of 17-α-hydroxyprogesterone caproate (17-OHPC) is utilized to prevent preterm birth, but the fetal safety of 17-OHPC is still a matter of concern. This study aimed to assess whether exposure to 17-OHPC during the second and third trimesters of pregnancy affects fetal biometry in twin gestations.This study included a subset of women with a twin pregnancy who had been previously included in a randomized clinical trial comparing the effectiveness of 17-OHPC and placebo on neonatal outcomes and preterm birth rates in multiple pregnancy. In the present study, the individual growth patterns of femur length, head circumference and abdominal circumference were compared between fetuses of women who had been randomized to receive weekly injections of either 17-OHPC (n = 52) or placebo (n = 58) at between 16-20 and 36 weeks' gestation.The three biometric variables assessed developed similarly in fetuses in both the group exposed to 17-OHPC and the placebo group during the second half of pregnancy. Birth weight adjusted for parity and fetal sex was also comparable between groups.The use of 17-OHPC has no adverse effects on fetal biometry and birth weight in twins.
- Published
- 2013
7. Prenatal diagnosis in two cases of de novo complex balanced chromosomal rearrangements. Three‐year follow‐up in one case
- Author
-
M. B. Tan‐Sindhunata, Birgit Sikkema-Raddatz, Rolf H. Sijmons, B. de Jong, R. Brunsting, AY van der Veen, B. De Vries, D. J. Bekedam, B. Van Aken, J. R. Beekhuis, and Human genetics
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pregnancy, High-Risk ,Prenatal diagnosis ,Autopsy ,Chromosomal translocation ,In situ hybridization ,Biology ,Pregnancy ,Prenatal Diagnosis ,medicine ,Humans ,Genetics (clinical) ,In Situ Hybridization, Fluorescence ,Genetics ,Gynecology ,Chromosome Aberrations ,Cytogenetics ,Obstetrics and Gynecology ,medicine.disease ,Chorionic Villi Sampling ,Karyotyping ,Amniocentesis ,Gestation ,%22">Fish ,Female ,Follow-Up Studies ,Maternal Age - Abstract
We report two cases of apparently balanced complex de novo chromosomal rearrangements (BCCR) detected prenatally at 17 weeks and 10 weeks of gestation, respectively. Chromosomes were studied using GTG‐banding and fluorescent in situ hybridization (FISH). In one case four chromosomes and in the other case three chromosomes were involved in the rearrangements. One of the pregnancies was terminated and no external or internal abnormalities were detected at autopsy. The other pregnancy continued to term. Level III ultrasound examination showed no abnormalities. The child is now 3 years old and has neither congenital anomalies nor evidence of delayed psychomotor development.
- Published
- 1995
8. No effect of the FitFor2 exercise programme on blood glucose, insulin sensitivity, and birthweight in pregnant women who were overweight and at risk for gestational diabetes: results of a randomised controlled trial
- Author
-
N, Oostdam, M N M, van Poppel, M G A J, Wouters, E M W, Eekhoff, D J, Bekedam, W K H, Kuchenbecker, H W P, Quartero, M H B, Heres, and W, van Mechelen
- Subjects
Adult ,Blood Glucose ,Glycated Hemoglobin ,Pregnancy Trimester, Third ,Pregnancy Outcome ,Gestational Age ,Fasting ,Overweight ,Exercise Therapy ,Pedigree ,Diabetes, Gestational ,Diabetes Mellitus, Type 2 ,Pregnancy ,Pregnancy Trimester, Second ,Birth Weight ,Humans ,Patient Compliance ,Female ,Insulin Resistance - Abstract
To evaluate the effectiveness of an exercise programme for pregnant women who were overweight or obese and at risk for gestational diabetes mellitus (GDM).Randomised controlled trial.Hospitals and midwifery practices in the Netherlands.Pregnant women who were overweight or obese and at risk for GDM between 2007 and 2011.Normal care was compared with an exercise training programme during pregnancy. The training consisted of aerobic and strength exercises, and was aimed at improving maternal fasting blood glucose, insulin sensitivity, and birthweight. Linear regression analyses were performed to determine the effects.Maternal outcome measures were fasting blood glucose (mmol/l), fasting insulin (pmol/l) and HbA1c (%), body weight (kg), body mass index (kg/m(2) ), and daily physical activity (minute/week). Offspring outcome measures were birthweight and fetal growth.A total of 121 women were randomly allocated to either a control (n = 59) or an intervention (n = 62) group. Intention-to-treat analysis showed that the exercise programme did not reduce maternal fasting blood glucose levels nor insulin sensitivity. Also, no effect was found on birthweight.The exercise intervention performed over the second and third trimester of pregnancy had no effects on fasting blood glucose, insulin sensitivity, and birthweight, most probably because of low compliance. The high prevalence of women at risk for GDM calls for further research on possible interventions that can prevent GDM, and other types of interventions to engage this target group in physical activity and exercise.
- Published
- 2012
9. The prevalence of type 2 diabetes and gestational diabetes mellitus in an inner city multi-ethnic population
- Author
-
R N, Weijers, D J, Bekedam, and H, Oosting
- Subjects
Adult ,Male ,Diabetes, Gestational ,Diabetes Mellitus, Type 2 ,Urban Population ,Pregnancy ,Population Surveillance ,Prevalence ,Humans ,Female ,Middle Aged ,Aged ,Netherlands - Abstract
Zeeburg', a multiethnic town borough in the Amsterdam-East region, has one of the city's highest rates of immigrants. In the total population of 19,825 Surinam (mainly Creole), Turkish, Moroccan, and Dutch adults the prevalence of known type 2 diabetes in 1994 and of gestational diabetes mellitus (GDM) between January 1992 and January 1997 was investigated. Based on World Health Organization (WHO) criteria of 1985, the age-standardized prevalence of type 2 diabetes was similar in men (6.4%; 95% confidence interval [CI]: 5.6-7.2) and women (6.4%: 95% CI: 5.8-7.0) for all ethnic groups combined. However, the age- and sex-standardized prevalence of type 2 diabetes was significantly greater in the non-Dutch inhabitants than in the Dutch inhabitants (17.3% [95% CI: 12.9-21.6] in Surinam inhabitants, 10.9% [95% CI: 9.7-12.2] in Turkish inhabitants, 12.4% [95% CI: 9.7-15.0] in Moroccan inhabitants, and 3.6% [95% CI: 3.2-3.9] in Dutch inhabitants). The odds ratios for type 2 diabetes for the separate immigrant groups relative to the Dutch group were 5.88 (95% CI: 4.54-7.69) for Surinam inhabitants, 4.00 (95% CI: 2.86-5.55) for Turkish inhabitants, and 4.17 (95% CI: 3.03-5.55) for Moroccan inhabitants. GDM was present in 2.59% of women of non-Dutch origin compared with 0.62% of women of Dutch origin. A significant positive association was found between the non-Dutch origin and the occurrence of GDM (chi2 = 6.7; p0.01). The study highlights a high prevalence of known type 2 diabetes and GDM in the immigrant inhabitants and emphasizes that appropriate interventions are necessarily with implications for health targets and capitation based budgets.
- Published
- 1998
10. Contributors
- Author
-
T Abels, Y K Abu-Osba, M S Ahmad, A M Al-Habbal, N A Albin, D P Alexander, S Alexander, D C Alverson, D C Andrews, K J Antila, J M Arnold, D J Bekedam, M Benthin, A Berec, W Berman, N Bernard, T Blomquist, H G Britton, P N Burns, F Cantraine, M C Carter, B Castle, M Cooper, P Dahl, G S Dawes, A J Dawson, O De Bakker, G De Toffoli Konishi, T Dillon, M S Dodgson, A T Doyle, P M Dunn, M Eldridge, A Elzouki, P S Eriksen, J M Evans, F Fallenstein, A Faquih, A L Fazary, G Gennser, R W Gill, N A J Gough, P Grella, V Martino, H J Hoogland, A Huch, R Huch, T C Jansen, O Jensen, P Johnson, N-P Jorgensen, V Kariniemi, J Kishan, J Kuzniar, R Leblanc, K Lindstrom, G Lingman, D W Lubbers, H M Maarof, I Z Mackenzie Nuffield, P H Magne, K Marsal, R Martino, J Melchior, N A Mir, J Morgenstern, A J Murrills Wessex Regional, J H Nagel, U Naumann, C Nickelsen, M F Niermeijer, R T Oja, R J Parsons, A Piela, C W G Redman, Nuffield, D Redstone, P Rolfe, G D Ryan, A R Sa'di, H Schettler, S Schmidt, J Schwers, F Sharp, J Sheddon, A S I Siimes, A Skret, N C Smith, T Somville, A Soni, D P Southall, W P Soutter, J A D Spencer, P A Stewart, L Svenningsen, Z Szmigiel, D G Talbert, A A Thalji, S G Thomsen, H M Tonge, O Th Uttendorfsky, I A Valimaki, A R Van der Wiel, D Veersema, C Velussi, A Verhoeff, K Vetter, G H A Visser, M Vossen, H C S Wallenburg, T Weber, T Wheeler, T H Wilmshurst, J W Wladmiroff, P Wolf Biomedical, J C Wollner, R S Wolton, and T Zaczek
- Published
- 1986
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.